RXi And EyeGate’s Needle-Free Ocular RNAi Delivery: Part 2

in-Pharma Technologist.com

RXi and EyeGate lift the lid on ocular delivery of RNAi therapeutics for retinal disorders as the two firm's team up to provide a unique needle-free solution.
  • <<
  • >>

Comments